This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Probiotics: Some individuals with chronic Lyme disease might consider probiotics to support gut health. Antibiotic treatments for Lyme disease may disrupt the balance of gut microbiota, and probiotics might help restore a healthy gut flora. However, evidence supporting their use specifically for chronic Lyme disease is lacking.
Vitamins and Minerals: Individuals with chronic Lyme disease might have specific nutritional needs or deficiencies due to factors such as compromised immune function or chronic inflammation. Supplements such as vitamins (e.g., vitamin D, B vitamins) or minerals (like magnesium or zinc) might be considered to address identified deficiencies. However, the use of supplements should be guided by healthcare professionals.
Omega-3 Fatty Acids: Omega-3 supplements containing EPA and DHA have anti-inflammatory properties and may support overall health. Some individuals might consider omega-3 supplementation for potential anti-inflammatory effects, although evidence supporting their use specifically for chronic Lyme disease is limited.
Herbal Supplements: Some individuals with chronic Lyme disease might explore herbal supplements such as Japanese knotweed, cat's claw, or garlic, among others. These herbs are believed by some to have antimicrobial or immune-modulating properties. However, the evidence supporting their effectiveness in treating chronic Lyme disease is limited and requires further research.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
mBio (mBio ) Vol: 11 Issue: 5 Pages: Pub: 2020 Sep 29 ePub: 2020 Sep 29 Authors Morrissette M,Pitt N,González A,Strandwitz P,Caboni M,Rebman AW,Knight R,D`Onofrio A,Aucott JN,Soloski MJ,Lewis K |
| 2 | 📚 |
Chronic Lyme Disease and Co-infections: Differential Diagnosis.
The open neurology journal (Open Neurol J ) Vol: 6 Issue: Pages: 158-78 Pub: 2012 ePub: 2012 Dec 28 Authors Berghoff W |
| 3 | 📚 |
Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
PloS one (PLoS One ) Vol: 10 Issue: 3 Pages: e0117207 Pub: 2015 ePub: 2015 Mar 25 Authors Feng J,Auwaerter PG,Zhang Y |
| 4 | 📚 |
Lyme disease: a growing threat to urban populations.
Proceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A ) Vol: 91 Issue: 7 Pages: 2378-83 Pub: 1994 Mar 29 ePub: Authors Steere AC |
| 5 | 📚 |
Lyme Disease: Diversity of Borrelia Species in California and Mexico Detected Using a Novel Immunoblot Assay.
Healthcare (Basel, Switzerland) (Healthcare (Basel) ) Vol: 8 Issue: 2 Pages: Pub: 2020 Apr 14 ePub: 2020 Apr 14 Authors Fesler MC,Shah JS,Middelveen MJ,Du Cruz I,Burrascano JJ,Stricker RB |
| 6 | 📚 |
Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United States.
MMWR. Morbidity and mortality weekly report (MMWR Morb Mortal Wkly Rep ) Vol: 66 Issue: 23 Pages: 607-609 Pub: 2017 Jun 16 ePub: 2017 Jun 16 Authors Marzec NS,Nelson C,Waldron PR,Blackburn BG,Hosain S,Greenhow T,Green GM,Lomen-Hoerth C,Golden M,Mead PS |
| 7 | 📚 |
What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome.
Cureus (Cureus ) Vol: 16 Issue: 7 Pages: e64987 Pub: 2024 Jul ePub: 2024 Jul 20 Authors Wester KE,Nwokeabia BC,Hassan R,Dunphy T,Osondu M,Wonders C,Khaja M |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 8 | 📚 |
Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 11 Issue: 7 Pages: Pub: 2022 Jul 7 ePub: 2022 Jul 7 Authors Horowitz RI,Freeman PR |
| 9 | 📚 |
Macrolide therapy of chronic Lyme Disease.
Medical science monitor : international medical journal of experimental and clinical research (Med Sci Monit ) Vol: 9 Issue: 11 Pages: PI136-42 Pub: 2003 Nov ePub: Authors Donta ST |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 893 | 1 | dapsone (antibiotic)[CFS] | (acnesone, dapsoderm-x, dapson, dapson fatol, dapson scanpharm, dapsone, dapsone actavis, dapsone auden, dapsone gsk, dapsone jacobus, dapsone link, dapsone nile, dapsone p d, dapson-fatol, disulone, lectisol, lennon-dapsone, protogen, sulfona zimaia, taiguk dapsone) |
| 931 | 1 | hydroxychloroquine sulfate,(prescription) | (axokine, dimard, hydrocad, hydroquin, ilinol, mcqs, plaquenil, plaquinol, quinilen, reumaquin, zy-q, apo-hydroxychloroquine sulfate, apo-hydroxyquine, be-easy, chloguin, dolquine, ercoquin, evoquin, fen le, geniquin, haloxin, hcqs, hydroquine, hydroxychloroquine sulfate actavis, hydroxychloroquine sulfate lenis, hydroxychloroquine zentiva, hydroxychloroquinesulfaat, metirel, narbon, oxiklorin, plaquenil-hydroxychloroquine sulfate zentiva, polirreumin, quensyl, quinoric, reumazine, reuquinol) |
| 1808 | 1 | macrolide () |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
